A fluorescent probe based on modulation of ESIPT signaling for the highly selective detection of N2H4 and cell-imaging.

The broad occurrence of the hydrazine (N2H4) residues in aqueousenvironment is a potential threat to human health. Currently, the mainstream strategy for designing N2H4-specific probes is to functionalize a fluorophore with nucleophilic sites for the reductionreaction with N2H4. In this work, we designed and synthesized an excited-state intermolecular proton transfer (inter-ESPT) fluorescent dye(2-amino-4-(4-methoxyphenyl)-7,8-dihydro-5H-spiro[quinoline-6,2'-[1,3]dioxolane]-3-carbonitrilem, DQN) and used it as a probe to sense N2H4. DQN exhibits blue fluorescence in conventional solvents, which is assigned to its normal emission. In the presence of N2H4, the probe DQN can anchor the N2H4 molecule via hydrogen binding, enabling DQN to undergo inter-ESPT process and light up its tautomeric fluorescence. From this basis, an inter-ESPT-based method for N2H4 detection was established, offering high selectivity and sensitivity (11.5 nM). Furthermore, we demonstrated that the probe DQN can recognize the proteins in living cells, affording cell-imaging. This research provides a promising sensing strategy for monitoring N2H4 in water environments and this inter-ESPT dye is a powerful tool for cell-imaging.

Tumor Microenvironment-Activated and Viral-Mimicking Nanodrugs Driven by Molecular Precise Recognition for dNTP Inhibition-Induced Synergistic Cancer Therapy.

The medical application of nanotechnology is promising for cancer chemotherapy. However, most of the small-molecule drug assemblies still have such disadvantages as serious drug leakage and nonideal synergistic mechanisms, resulting in undesired therapeutic effect. Both nucleoside analogue-based clofarabine (CA) and methotrexate (MTX) were used as the first-line anticancer medication. However, a single-agent chemotherapy still faced many challenges including low bioavailability and toxic side effects to normal tissues due to nonspecific biodistribution of drugs. Herein, we designed and fabricated novel viral-mimicking and carry-free nanodrugs (CA-MTX NPs) via molecular recognition-driven precise self-assembly between CA and MTX. After introduction of mild acid-responsive PEG-lipid on the surface of CA-MTX NPs, the synthetic nanodrugs with a diameter of ∼150 nm exhibited tumor microenvironment-activated characteristics and self-targeting property. The results suggested that our nanodrugs could achieve superior tumor accumulation and synergistically promote the tumor suppression by collaboratively inhibiting dNTP pools. We foresaw that the well-designed smart nanodrugs delivery system would open a new avenue in synergistic cancer therapeutics.

Recent Progress in Chemical Modification of Proteins.

Chemical modification of proteins is important for creating a myriad of engineered proteins and for elucidating the function and dynamics of proteins in live cells. A wide variety of chemical protein modification methods have been developed and can be categorized into three classes: (i) modification of proteins using the reactivity of naturally occurring amino acids; (ii) modification by bioorthogonal reactions using unnatural amino acids, most of which can be site-selectively incorporated into proteins-of-interest using genetic codon expansion techniques; and (iii) recognition driven chemical modification, which is the only approach that allows modification of endogenous proteins without any genetic manipulation even under heavily crowded and multi-molecular conditions, as in live cells and organisms. All of these approaches have merits and limitations. In this review, we summarize these approaches and discuss their characteristics with respect to specificity, reaction rate and versatility.